Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
N Engl J Med
; 382(20): 1894-1905, 2020 05 14.
Article
in En
| MEDLINE
| ID: mdl-32402160
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Carcinoma, Hepatocellular
/
Antibodies, Monoclonal, Humanized
/
Programmed Cell Death 1 Receptor
/
Bevacizumab
/
Liver Neoplasms
Type of study:
Clinical_trials
Aspects:
Patient_preference
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
N Engl J Med
Year:
2020
Document type:
Article